BSE filing, NSE: VIVOBIOT. Summary written from the filing by ALFA Finder's alert engine.
Vivo Bio Tech Ltd: key numbers
- Share price
- ₹13.85
- Market cap
- ₹22.34 Cr
- Revenue (annual)
- ₹53.33 Cr
- Net profit (annual)
- ₹-1.71 Cr
- P/E (TTM)
- -7.8×Sector 46.1×
- Promoter holding
- 22.51%-8.11% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vivo Bio Tech Ltd
All →Vivo Bio Tech Other Announcement
The company submitted its periodic shareholding pattern for the quarter ended September 30, 2026, disclosing its promoter and public shareholding as mandated by SEBI.
Vivo Bio Tech Adverse Business Impact
Vivo Bio Tech reports a fire at its Telangana research facility damaging labs, equipment, and samples. No casualties; damage under assessment with adequate insurance coverage in place.
Vivo Bio Tech Other Announcement
Vivo Bio Tech Ltd filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Vivo Bio Tech Management Change
Vivo Bio Tech Limited announced the re-appointment of Sri Kalyan Kompella and Sankaranarayanan Alangudi as Executive Directors, effective November 2026 and January 2027 respectively.
Vivo Bio Tech Annual General Meeting
Vivo Bio Tech Ltd held its 39th Annual General Meeting on September 30, 2026, to adopt financial statements and re-appoint directors.
Vivo Bio Tech Other Announcement
Vivo Bio Tech has sent letters to shareholders without registered email addresses, providing a web-link to access the Annual Report for the financial year 2025-26.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.